Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Carotid and Renal Artery Stents Market Report Overview
The carotid and renal artery stents market size was $703.8 million in 2023 and will grow at a CAGR of more than 4% from 2023 to 2033. Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries. Renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. Renal arteries can become narrowed due to plaque formation in the inner surface of the arteries.
Carotid and Renal Artery Stents Market Outlook 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Carotid and Renal Artery Stents Market Forecast, Download a Free Sample Report
The carotid and renal artery stents market research report identifies quantitative market trends within cardiovascular devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the carotid and renal artery stents market for 2020 and beyond. Furthermore, the report provides carotid and renal artery stents market share by a company that will help in identifying untapped market opportunities.
Market Size (2023) | $703.8 million |
CAGR (2023-2033) | >4% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments | · Carotid Artery Bare Metal Stents
· Renal Artery Bare Metal Stents · Transcarotid Stent System |
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Carotid and Renal Artery Stents Market Segments
The key segments in the carotid and renal artery stents market are carotid artery bare metal stents, renal artery bare metal stents, and transcarotid stent systems among others. In 2023, the carotid artery bare metal stents segment accounted for the highest share of the market. A carotid artery bare metal stent is a metal-mesh tube that is implanted to increase the flow of blood in a narrowed carotid artery.
Carotid and Renal Artery Stents Market Analysis by Segments, 2023 (%)
Buy the Full Report for more Segment-Wise Insights into the Carotid and Renal Artery Stents Market,
Download a Free Sample Report
Carotid and Renal Artery Stents Market Segmentation by Regions
The key regions in the carotid and renal artery stents market are Asia-Pacific, Europe, the Middle East, and Africa. North America and South and Central America are other leading regional markets. In 2023, the European carotid and renal artery stents market was the leading regional market.
Carotid artery stenting will increase but at a slow pace as it is difficult to properly diagnose carotid artery stenosis. Additionally, doctors prefer open surgery over stenting procedures. However, renal artery stenting will increase at a higher rate because doctors prefer stenting in cases of severe renal deterioration or cases of refractory hypertension.
Carotid and Renal Artery Stents Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Carotid and Renal Artery Stents Market, Download a Free Sample Report
Carotid and Renal Artery Stents Market – Competitive Landscape
In 2023, Abbott Laboratories accounted for the highest share of the carotid and renal artery stents market
The major players in the carotid and renal artery stents market are:
- Abbott Laboratories
- Boston Scientific Corp
- Hellman & Friedman LLC
- Medtronic Plc
- Silk Road Medical Inc
It is challenging for any new company to get established in this market because stenting has limitations in CAS (carotid artery stents) and RAS (renal artery stents). Additionally, it is very difficult to determine the optimal treatment for a given patient. Due to the lack of proper trial data and uncertain repercussions of the disease, it is difficult for smaller companies to grow in the carotid and renal artery stents market.
Carotid and Renal Artery Stents Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Carotid and Renal Artery Stents Market, Download a Free Sample Report
Carotid and Renal Artery Stents Market Dynamics
- Drivers: Investments into healthcare infrastructure and alternative approaches to treat CAS & RAS will continue to drive market growth. According to several secondary research sources, stents have better outcomes than open surgery. In the case of CAS, open surgery has the risk of developing debilitating and life-altering pharyngolaryngeal dysfunction. In the case of RAS, major pitfalls linked with surgery have been observed to be twofold higher as compared to endovascular procedures. This has resulted in angioplasty becoming a first-choice treatment.
- Barriers: A major barrier to market growth is a lack of highly trained practitioners capable of performing these procedures. In cases of CAS, the number of risks involved with interventions is similar in both open surgery and stenting procedures, which makes it essential to properly characterize which approach will benefit an individual patient the most. In cases of RAS, one can deploy a stent in the renal artery only when stenosis is caused due to atherosclerotic plaque and not Fibromuscular dysplasia.
- Future Outlook: Technological advancements in this field will drive continual growth and innovation due to the reduced complication rates and better patient outcomes that are possible with carotid and renal stenting. Despite issues with recurrent stenosis, the device possesses advanced capabilities to dramatically increase the safety and outcomes of patients undergoing treatment. This factor is expected to encourage companies to invest in this technology and to draw new players to enter the market.
Purchase the Complete Report for Additional Insights on the Carotid and Renal Artery Stents Market Dynamics, Get a Free Sample Report Here
Segments Covered in this Report
Carotid and Renal Artery Stents Segment Outlook ($ Million, 2015-2033)
- Carotid Artery Bare Metal Stents
- Renal Artery Bare Metal Stents
- Transcarotid Stent System
Carotid and Renal Artery Stents Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
The carotid and renal artery stents market research report includes an insightful review of the key industry trends.
- The carotid and renal artery stents market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global carotid and renal artery stents market insights:
- The carotid and renal artery stents market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Carotid and renal artery stents market SWOT analysis.
- The report provides trends and carotid and renal artery stents market competitive dynamics.
Buy the Full Report for More Insights on the Carotid and Renal Artery Stents Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered: Abbott Laboratories, Cordis Corp, Boston Scientific Corp, Silk Road Medical Inc, Medtronic Plc, Terumo Corp, Cook Medical Inc, Biotronik SE & Co KG, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the carotid and renal artery stents market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the carotid and renal artery stents market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the impact of COVID-19 on the carotid and renal artery stents market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the carotid and renal artery stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the carotid and renal artery stents market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of carotid and renal artery stents market share by company. Identify strong competitors and create winning strategies to stand out in the global carotid and renal artery stents market.
- Track device sales in the global and country-specific Carotid and Renal Artery Stents market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Cordis Corp
Boston Scientific Corp
Silk Road Medical Inc
Medtronic Plc
Terumo Corp
Cook Medical Inc
Biotronik SE & Co KG
Others
Frequently asked questions
-
What was the carotid and renal artery stents market size in 2023?
The size of the carotid and renal artery stents market was $703.8 million in 2023.
-
What will the CAGR of the carotid and renal artery stents market be during the forecast period?
The carotid and renal artery stents market will grow at a CAGR of more than 4% during 2023-2033.
-
Which region held the largest share of the carotid and renal artery stents market in 2023?
Europe was the largest regional market for carotid and renal artery stents in 2023.
-
Which are the leading players in the carotid and renal artery stents market?
A few of the leading carotid and renal artery stents market companies are Abbott Laboratories, Boston Scientific Corp, Hellman & Friedman LLC, Medtronic Plc, and Silk Road Medical Inc. among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.